SHH · 688315.SS
Novogene Co., Ltd.
CN¥18.31-CN¥0.94 (-4.88%)
Novogene Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 21.85% below the high.
Loading market information…
SHH · 688399.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Jiangsu Bioperfectus Technologies Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 65.68% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Jiangsu Bioperfectus Technologies Co., Ltd.’s forward annual dividend is CN¥6.76 per share, paid annual. The forward yield is 30.99% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Jiangsu Bioperfectus Technologies Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Jiangsu Bioperfectus Technologies Co., Ltd. is engaged in the research, development, manufacturing, and marketing of in vitro diagnostic (IVD) solutions across China. The company's core offerings include a range of diagnostic reagents, complementary detection equipment, and comprehensive in vitro testing services. Established in 2010, its operations are based in Taizhou, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:02 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥18.31-CN¥0.94 (-4.88%)
Novogene Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 21.85% below the high.
CN¥13.28-CN¥0.26 (-1.92%)
Jiangxi Fushine Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 45.08% below the high.
CN¥37.84+CN¥0.31 (+0.83%)
Hangzhou Biotest Biotech Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.77% below the high.
CN¥11.14-CN¥0.07 (-0.62%)
Wuhan Keqian Biology Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 37.45% below the high.
CN¥11.93-CN¥0.23 (-1.89%)
Jiangsu Aidea Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 47.1% below the high.
CN¥24.81-CN¥1.73 (-6.52%)
Beijing Konruns Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 51.12% below the high.
CN¥12.47-CN¥0.32 (-2.5%)
Jiangsu Lianhuan Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 61.36% below the high.
CN¥14.80-CN¥0.66 (-4.27%)
Hefei Lifeon Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 45.21% below the high.
